← 28 September 2026's Current Affairs · Karnataka GS-2 Prelims ★★★★☆ Mains ★★★★☆
Karnataka flags steep markups on critical drugs
খবরে কেন?
Cancer drugs marked up 70 times over cost: the price-control law meant to stop this
Karnataka's Health Minister flagged markups of up to 70 times procurement cost on critical drugs, citing weak price-control enforcement.
Why it matters: GS-2 core; factual, Prelims-type; Karnataka-specific
What you need to know
2 মিনিট
Karnataka's Health Minister said that some cancer, kidney and HIV/AIDS medications were being sold to patients at markups of up to 70 times their procurement cost in private hospitals and pharmacies, and flagged the need for stronger price controls.
Drug pricing in India for essential medicines is regulated by the National Pharmaceutical Pricing Authority (NPPA) under the Drugs (Prices Control) Order, which caps trade margins on certain formulations.
The Minister's remarks pointed to gaps in enforcement for high-cost critical-illness drugs.
সূত্র: Topper IAS editorial (PIB / The Hindu / Indian Express)
মূল তথ্য
Remember these
- Karnataka's Health Minister flagged markups of up to 70 times procurement cost on some critical drugs
- Cancer, kidney and HIV/AIDS medications named as commonly overpriced in private hospitals and pharmacies
- NPPA regulates essential drug prices under the Drugs (Prices Control) Order
- The Order caps trade margins on certain scheduled formulations
- Minister pointed to weak enforcement for high-cost critical-illness drugs
প্রিলিমস · মেইনস
How the exam will ask it
প্রিলিমস
- Karnataka's Health Minister flagged markups of up to 70 times procurement cost on certain cancer, kidney and HIV/AIDS drugs sold in private hospitals and pharmacies.
- The National Pharmaceutical Pricing Authority (NPPA) regulates prices of essential and scheduled medicines under the Drugs (Prices Control) Order.
- The Drugs (Prices Control) Order caps trade margins on certain drug formulations to prevent overpricing.
- The Minister's remarks highlighted gaps in enforcement of price controls for high-cost critical-illness drugs.
মেইনস
GS Paper 2 - Governance/Health policy: unchecked markups on critical-illness drugs expose gaps in enforcing the NPPA's mandate under the Drugs (Prices Control) Order, raising patients' out-of-pocket burden and undermining affordable healthcare access. The way forward lies in extending trade-margin caps to more critical formulations, strengthening state-level price monitoring, and coordinating Centre-State action against violations.
Quick recall
Answer before you reveal
The Central regulator responsible for capping trade margins and prices of essential medicines in India, relevant to concerns raised over high drug markups in Karnataka, is the:
- Central Drugs Standard Control Organisation
- National Pharmaceutical Pricing Authority
- Food Safety and Standards Authority of India
- Pharmacy Council of India
উত্তর দেখুন
উত্তর: B — Correct: National Pharmaceutical Pricing Authority - regulates drug prices and trade margins under the Drugs (Prices Control) Order. • Central Drugs Standard Control Organisation - wrong: regulates drug approval/safety, not price. • Food Safety and Standards Authority of India - wrong: regulates food safety. • Pharmacy Council of India - wrong: regulates the pharmacy profession.
Convert this topic into marks
Today's 10-MCQ test · instant analysis · Powered by AdaptIQ